Syndax Pharmaceuticals, Inc

(NASDAQ:SNDX)

Latest On Syndax Pharmaceuticals, Inc (SNDX):

Date/Time Type Description Signal Details
2023-05-09 04:24 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.59 beats by $0.01N/A
2023-05-09 04:24 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 02:38 ESTNewsSyndax Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-03-04 02:40 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 16:35 ESTNewsSyndax Pharmaceuticals: 2023 Is A Pivotal YearN/A
2023-03-01 01:25 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.62 beats by $0.04N/A
2023-02-27 19:50 ESTNewsSyndax Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-01-12 14:22 ESTNewsSyndax Pharmaceuticals (SNDX) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- SlideshowN/A
2022-12-17 03:56 ESTNewsSyndax Pharmaceuticals (SNDX) Presents at 64th ASH Annual Meeting & ExpositionN/A
2022-12-12 19:48 ESTNewsKura Oncology falls, Syndax gains after Phase 1/2 data for leukemia candidatesN/A
2022-12-10 16:27 ESTNewsSyndax Pharmaceuticals: Today's Best Nearby Biotech Cap-Gain ProspectN/A
2022-12-07 20:58 ESTNewsSyndax Pharmaceuticals prices $150M offeringN/A
2022-12-07 01:27 ESTNewsSyndax Pharma to sell $150M stock in public offeringN/A
2022-12-05 14:27 ESTNewsSyndax receives breakthrough therapy tag for revumenib to treat acute leukemiaN/A
2022-11-06 14:31 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q3 2022 Earnings Call TranscriptN/A
2022-11-06 14:31 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-04 08:33 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.58 beats by $0.07; updates FY22 guidanceN/A
2022-11-02 23:19 ESTNewsSyndax Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.62N/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 07:37 ESTNewsSyndax Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-06-13 12:56 ESTNewsKeith Goldan joins Syndax Pharmaceuticals as CFON/A
2022-05-10 14:01 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-10 14:01 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-09 16:51 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.63N/A
2022-05-09 00:26 ESTNewsSyndax Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-08 05:11 ESTNewsSyndax Pharmaceuticals: Cash-Rich With 2 Promising DrugsN/A
2022-03-25 00:25 ESTNewsSyndax Pharmaceuticals (SNDX) Presents At Barclays Global Healthcare ConferenceN/A
2022-03-02 06:49 ESTNewsSyndax appoints former Alnylam executive as new medical chiefN/A
2022-03-02 06:49 ESTNewsSyndax Pharmaceuticals GAAP EPS of $1.81 beats by $1.84, revenue of $126.6M beats by $67.92MN/A
2022-03-02 06:48 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 18:56 ESTNewsSyndax Pharmaceuticals Q4 Earnings PreviewN/A
2022-01-29 06:36 ESTNewsSyndax Pharmaceuticals (SNDX) Investor Presentation - SlideshowN/A
2021-12-23 00:22 ESTNewsSyndax's SNDX-5613 an Orphan Drug in Europe for acute myeloid leukemiaN/A
2021-12-16 14:02 ESTNewsSyndax Pharma raises $75M via stock offeringN/A
2021-12-15 18:28 ESTNewsSyndax Pharmaceuticals drops 6% following underwritten stock offeringN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals EPS misses by $0.35, misses on revenueN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-14 18:13 ESTNewsSyndax Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-11-04 16:35 ESTNewsSyndax Pharma falls after updating early-stage data for leukemia therapyN/A
2021-10-05 15:59 ESTNewsSyndax Pharma CFO Daphne Karydas to resign to pursue another opportunityN/A
2021-09-28 02:06 ESTNewsIncyte and Syndax in pact for xatilimab targeting immune-related conditionsN/A
2021-08-10 12:01 ESTNewsSyndax Pharmaceuticals EPS beats by $0.28, beats on revenueN/A
2021-08-10 12:00 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-10 11:59 ESTNewsSyndax Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-07-22 02:04 ESTNewsSyndax Pharmaceuticals: Updated Analysis After Reporting Interim Phase 1 DataN/A
2021-07-22 02:02 ESTNewsCanopy upgraded on economy reopening, Xeris PT cut on acquisition news, and more in analyst actionN/A
2021-07-22 01:35 ESTNewsSyndax shares rise on FDA Fast Track status for leukemia treatment SNDX-5613N/A

About Syndax Pharmaceuticals, Inc (SNDX):

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. The company was incorporated in 2005 and is headquartered in Waltham, Massachusetts.

See Advanced Chart

General

  • Name Syndax Pharmaceuticals, Inc
  • Symbol SNDX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 43
  • Fiscal Year EndDecember
  • IPO Date2016-03-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.syndax.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 634.74
  • Price/Book (Most Recent Quarter) 4.43
  • Enterprise Value Revenue 542.55
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.19
  • Next Year EPS Estimate -$2.17
  • Next Quarter EPS Estimate -$0.47
  • Operating Margin -4708%
  • Return on Assets -25%
  • Return on Equity -52%
  • Revenue 1.52 million
  • Earnings Per Share -$2.36
  • Revenue Per Share $0.04
  • Gross Profit 1.52 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.16 billion
  • EBITDA -67280000
  • PE Ratio -125.39
  • Analyst Target Price $32.14
  • Book Value Per Share $5.27
View More

Share Statistics

  • Shares Outstanding 48.24 million
  • Shares Float 42.95 million
  • % Held by Insiders 645%
  • % Held by Institutions 78.88%
  • Shares Short 4.93 million
  • Shares Short Prior Month 4.93 million
  • Short Ratio 9.27
  • Short % of Float 11%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.84
  • 52 Week High $27.12
  • 52 Week Low $8.18
  • 50 Day Moving Average 22.33
  • 200 Day Moving Average 20.55
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Syndax Pharmaceuticals, Inc (SNDX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Syndax Pharmaceuticals, Inc (SNDX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-08$380000-$0.44-$0.5113.23%
2020-09-302020-11-02$N/A-$0.46-$0.43-6.75%
2020-06-302020-08-06$N/A-$0.42-$0.444.76%
2020-03-312020-05-07$379000-$0.56-$0.53-6.65%
2019-12-312020-03-03$380000-$0.44-$0.43-1.31%
2019-09-302019-11-07$379000-$0.41-$0.4813.92%
2019-06-302019-08-07$379000-$0.47-$0.470.76%
2019-03-312019-05-06$379000-$0.53-$0.554.14%
2018-12-312019-03-07$379000-$0.70-$0.64-9.43%
2018-09-302018-11-05$379000-$0.68-$0.7610.21%
2018-06-302018-08-07$379000-$0.74-$0.8916.94%
2018-03-312018-05-08$379000-$0.79-$0.9517.15%
2017-12-312018-03-05$1.19 million-$0.80-$0.77-3.67%
2017-09-302017-11-07$305000-$0.68-$0.8216.63%
2017-06-302017-08-10$305000-$0.70-$0.8214.83%
2017-03-312017-05-08$305000-$0.71-$0.710.56%
2016-12-312017-03-02$305000-$0.59-$0.7419.79%
2016-09-302016-11-10$305000-$0.84-$0.82-2.78%
2016-06-302016-08-09$305000-$0.47-$0.5412.18%
2016-03-312016-05-16$305000-$0.73-$0.48-52.22%

Syndax Pharmaceuticals, Inc (SNDX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Syndax Pharmaceuticals, Inc (SNDX) Chart:

Syndax Pharmaceuticals, Inc (SNDX) News:

Below you will find a list of latest news for Syndax Pharmaceuticals, Inc (SNDX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Syndax Pharmaceuticals, Inc (SNDX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-07-1750CALL0 0280.59TRUE00
2026-07-1790CALL0 0203.16TRUE00
2026-07-17100CALL0 0205.81TRUE00
2026-07-17110CALL0 0169.25TRUE00
2026-07-17120CALL0 3153.13TRUE00
2026-07-17130CALL0 0122.46TRUE00
2026-07-17140CALL0 748.76TRUE00
2026-07-17150CALL0 31102.75TRUE00
2026-07-17160CALL0 0101.99TRUE00
2026-07-17172.97CALL50 52104.03TRUE2.970
2026-07-17181.95CALL0 9957.92TRUE00
2026-07-17191CALL0 61979.74TRUE00
2026-07-17201.15CALL25 11080.4FALSE0.250.28
2026-07-17210.95CALL1 43965.64FALSE0.950
2026-07-17220.5CALL11 4065.83FALSE00
2026-07-17230.31CALL7 2663.03FALSE0.010.03
2026-07-17240.2CALL16 19869.96FALSE0.20
2026-07-17250.25CALL1 34178.12FALSE0.250
2026-07-17260CALL0 78103.68FALSE00
2026-07-17270CALL0 0111.47FALSE00
2026-07-17280CALL0 81118.78FALSE00
2026-07-17290CALL0 2168.14FALSE00
2026-07-17300CALL0 95132.22FALSE00
2026-07-17310CALL0 1182.42FALSE00
2026-07-17320CALL0 1152.31FALSE00
2026-07-17330CALL0 5149.99FALSE00
2026-07-17340CALL0 0199.79FALSE00
2026-07-17350CALL0 2197.56FALSE00
2026-07-17360CALL0 0211.04FALSE00
2026-07-17370CALL0 0216.33FALSE00
2026-07-17380CALL0 0174.93FALSE00
2026-07-17390CALL0 0188.17FALSE00
2026-07-17400CALL0 0183.66FALSE00
2026-07-1750PUT0 0378.91FALSE00
2026-07-1790PUT0 0211.35FALSE00
2026-07-17100PUT0 0199.88FALSE00
2026-07-17110PUT0 0175.99FALSE00
2026-07-17120PUT0 0164.37FALSE00
2026-07-17130PUT0 0143.08FALSE00
2026-07-17140PUT0 0123.08FALSE00
2026-07-17150PUT0 12143.2FALSE00
2026-07-17160PUT0 2069.69FALSE00
2026-07-17170.7PUT0 968.91FALSE00
2026-07-17180.85PUT0 2766.81FALSE00
2026-07-17191.2PUT1 4371.53TRUE1.20
2026-07-17201.58PUT5 7553.15TRUE1.580
2026-07-17212.29PUT3 260.54TRUE2.290
2026-07-17220PUT0 040.67TRUE00
2026-07-17230PUT0 10TRUE00
2026-07-17240PUT0 40TRUE00
2026-07-17250PUT0 100TRUE00
2026-07-17260PUT0 00TRUE00
2026-07-17277.7PUT2 00TRUE7.70
2026-07-17288.8PUT2 00TRUE8.80
2026-07-17290PUT0 0100.77TRUE00
2026-07-17300PUT0 00TRUE00
2026-07-173111.7PUT2 00TRUE11.70
2026-07-173212.7PUT2 00TRUE12.70
2026-07-173313.7PUT2 10TRUE13.70
2026-07-17340PUT0 00TRUE00
2026-07-17350PUT0 00TRUE00
2026-07-17360PUT0 00TRUE00
2026-07-17370PUT0 00TRUE00
2026-07-17380PUT0 00TRUE00
2026-07-17390PUT0 00TRUE00
2026-07-17400PUT0 00TRUE00
2026-08-21100CALL0 0127.02TRUE00
2026-08-21110CALL0 0123.28TRUE00
2026-08-21120CALL0 0107.71TRUE00
2026-08-21130CALL0 0105.34TRUE00
2026-08-21140CALL0 098.48TRUE00
2026-08-21150CALL0 686.31TRUE00
2026-08-21160CALL0 191.28TRUE00
2026-08-21170CALL0 086.77TRUE00
2026-08-21180CALL0 284.15TRUE00
2026-08-21190CALL0 487.83TRUE00
2026-08-21202CALL0 1380.06FALSE00
2026-08-21210CALL0 784.87FALSE00
2026-08-21221.45CALL0 1076.07FALSE00
2026-08-21230CALL0 085.38FALSE00
2026-08-21240.9CALL0 2362.9FALSE00
2026-08-21250.7CALL0 30486.84FALSE00
2026-08-21260CALL0 989.34FALSE00
2026-08-21270CALL0 1695.14FALSE00
2026-08-21280CALL0 0110.26FALSE00
2026-08-21290CALL0 499.4FALSE00
2026-08-21300CALL0 50118.57FALSE00
2026-08-21310CALL0 0123.27FALSE00
2026-08-21320CALL0 0102.06FALSE00
2026-08-21330CALL0 0130.98FALSE00
2026-08-21340CALL0 0135.03FALSE00
2026-08-21350CALL0 0107.65FALSE00
2026-08-21360CALL0 0121.98FALSE00
2026-08-21370CALL0 0144.08FALSE00
2026-08-21380CALL0 0148.58FALSE00
2026-08-21390CALL0 0131.71FALSE00
2026-08-21400CALL0 0153.97FALSE00
2026-08-21100PUT0 0135.11FALSE00
2026-08-21110PUT0 0133.87FALSE00
2026-08-21120PUT0 0144.48FALSE00
2026-08-21130PUT0 0108.6FALSE00
2026-08-21140PUT0 0117.11FALSE00
2026-08-21150PUT0 0103.56FALSE00
2026-08-21160PUT0 096.13FALSE00
2026-08-21170PUT0 0100.29FALSE00
2026-08-21180PUT0 082.8FALSE00
2026-08-21190PUT0 192.29TRUE00
2026-08-21200PUT0 30177.47TRUE00
2026-08-21210PUT0 676.81TRUE00
2026-08-21220PUT0 471.88TRUE00
2026-08-21230PUT0 069.02TRUE00
2026-08-21240PUT0 454.82TRUE00
2026-08-21250PUT0 652.4TRUE00
2026-08-21260PUT0 069.08TRUE00
2026-08-21270PUT0 069.01TRUE00
2026-08-21280PUT0 067.28TRUE00
2026-08-21290PUT0 071.72TRUE00
2026-08-21300PUT0 00TRUE00
2026-08-21310PUT0 00TRUE00
2026-08-21320PUT0 00TRUE00
2026-08-21330PUT0 00TRUE00
2026-08-21340PUT0 00TRUE00
2026-08-21350PUT0 00TRUE00
2026-08-21360PUT0 00TRUE00
2026-08-21370PUT0 00TRUE00
2026-08-21380PUT0 00TRUE00
2026-08-21390PUT0 00TRUE00
2026-08-21400PUT0 00TRUE00
2026-09-18110CALL0 0101.28TRUE00
2026-09-18120CALL0 099.52TRUE00
2026-09-18130CALL0 093.68TRUE00
2026-09-18140CALL0 091.26TRUE00
2026-09-18150CALL0 087.45TRUE00
2026-09-18160CALL0 085.82TRUE00
2026-09-18170CALL0 084.28TRUE00
2026-09-18180CALL0 080.7TRUE00
2026-09-18190CALL0 078.02TRUE00
2026-09-18202.6CALL1 3178.08FALSE2.60
2026-09-18210CALL0 178.18FALSE00
2026-09-18220CALL0 40075.13FALSE00
2026-09-18230CALL0 883.76FALSE00
2026-09-18240CALL0 079.35FALSE00
2026-09-18250.9CALL10 3076.58FALSE-0.2-0.18
2026-09-18260CALL0 30479.65FALSE00
2026-09-18270CALL0 286.16FALSE00
2026-09-18280CALL0 298.52FALSE00
2026-09-18290CALL0 2102.25FALSE00
2026-09-18300CALL0 1104.94FALSE00
2026-09-18310CALL0 1108.15FALSE00
2026-09-18320CALL0 3111.14FALSE00
2026-09-18330CALL0 096.28FALSE00
2026-09-18340CALL0 0117.37FALSE00
2026-09-18350CALL0 3120.66FALSE00
2026-09-18360CALL0 0122.97FALSE00
2026-09-18370CALL0 0125.99FALSE00
2026-09-18380CALL0 0103.62FALSE00
2026-09-18390CALL0 0125.48FALSE00
2026-09-18400CALL0 0133.53FALSE00
2026-09-18110PUT0 0112.04FALSE00
2026-09-18120PUT0 0123.27FALSE00
2026-09-18130PUT0 0110.89FALSE00
2026-09-18140PUT0 0101.99FALSE00
2026-09-18150PUT0 089.51FALSE00
2026-09-18160PUT0 083.91FALSE00
2026-09-18170PUT0 091.62FALSE00
2026-09-18180PUT0 085.03FALSE00
2026-09-18190PUT0 174.28TRUE00
2026-09-18200PUT0 272.58TRUE00
2026-09-18210PUT0 071.5TRUE00
2026-09-18220PUT0 30069.76TRUE00
2026-09-18230PUT0 168.05TRUE00
2026-09-18240PUT0 065.68TRUE00
2026-09-18250PUT0 268.33TRUE00
2026-09-18260PUT0 068.55TRUE00
2026-09-18278.59PUT0 263.76TRUE00
2026-09-18280PUT0 074.21TRUE00
2026-09-18290PUT0 067.42TRUE00
2026-09-18300PUT0 076.06TRUE00
2026-09-18310PUT0 065.52TRUE00
2026-09-18320PUT0 068.75TRUE00
2026-09-18330PUT0 00TRUE00
2026-09-18340PUT0 00TRUE00
2026-09-18350PUT0 090.54TRUE00
2026-09-18360PUT0 00TRUE00
2026-09-18370PUT0 00TRUE00
2026-09-18380PUT0 093.26TRUE00
2026-09-18390PUT0 095.89TRUE00
2026-09-18400PUT0 00TRUE00
2026-10-16109.3CALL1 1108.84TRUE9.30
2026-10-16110CALL0 0100.78TRUE00
2026-10-16120CALL0 092.84TRUE00
2026-10-16130CALL0 290.86TRUE00
2026-10-16140CALL0 089.32TRUE00
2026-10-16150CALL0 2083.49TRUE00
2026-10-16160CALL0 085.64TRUE00
2026-10-16170CALL0 079.65TRUE00
2026-10-16180CALL0 076.22TRUE00
2026-10-16190CALL0 177.83TRUE00
2026-10-16200CALL0 376.56FALSE00
2026-10-16210CALL0 076.63FALSE00
2026-10-16220CALL0 365.36FALSE00
2026-10-16230CALL0 078.22FALSE00
2026-10-16240CALL0 065.4FALSE00
2026-10-16250CALL0 3872.46FALSE00
2026-10-16260CALL0 184.8FALSE00
2026-10-16270CALL0 377.14FALSE00
2026-10-16280CALL0 187.25FALSE00
2026-10-16290CALL0 080.24FALSE00
2026-10-16300CALL0 692.26FALSE00
2026-10-16310CALL0 095.09FALSE00
2026-10-16320CALL0 097.73FALSE00
2026-10-16330CALL0 0100.19FALSE00
2026-10-16340CALL0 0102.49FALSE00
2026-10-16350CALL0 0104.64FALSE00
2026-10-16360CALL0 0106.66FALSE00
2026-10-16370CALL0 0108.55FALSE00
2026-10-16380CALL0 0111.08FALSE00
2026-10-16390CALL0 0112.75FALSE00
2026-10-16400CALL0 0115.11FALSE00
2026-10-16100PUT0 094.34FALSE00
2026-10-16110PUT0 1120.99FALSE00
2026-10-16120PUT0 0110.36FALSE00
2026-10-16130PUT0 0101.18FALSE00
2026-10-16140PUT0 093.07FALSE00
2026-10-16150PUT0 585.71FALSE00
2026-10-16160PUT0 092.76FALSE00
2026-10-16172.92PUT0 677.49FALSE00
2026-10-16180PUT0 1565.79FALSE00
2026-10-16190PUT0 072.12TRUE00
2026-10-16200PUT0 071.72TRUE00
2026-10-16210PUT0 071.4TRUE00
2026-10-16220PUT0 171.26TRUE00
2026-10-16236.48PUT0 3166.57TRUE00
2026-10-16240PUT0 164.99TRUE00
2026-10-16250PUT0 1065.02TRUE00
2026-10-16260PUT0 064.18TRUE00
2026-10-16270PUT0 067.07TRUE00
2026-10-16280PUT0 061.02TRUE00
2026-10-16290PUT0 071.84TRUE00
2026-10-16300PUT0 071.95TRUE00
2026-10-16310PUT0 073.45TRUE00
2026-10-16320PUT0 070.34TRUE00
2026-10-16330PUT0 075.58TRUE00
2026-10-16340PUT0 070.9TRUE00
2026-10-16350PUT0 066.23TRUE00
2026-10-16360PUT0 068.67TRUE00
2026-10-16370PUT0 071.04TRUE00
2026-10-16380PUT0 077.62TRUE00
2026-10-16390PUT0 00TRUE00
2026-10-16400PUT0 00TRUE00
2027-01-1530CALL0 0178.73TRUE00
2027-01-1550CALL0 0143.86TRUE00
2027-01-1580CALL0 13113.15TRUE00
2027-01-1590CALL0 0104.02TRUE00
2027-01-15100CALL0 43106.96TRUE00
2027-01-15110CALL0 0106.09TRUE00
2027-01-15120CALL0 098.43TRUE00
2027-01-15130CALL0 7899.02TRUE00
2027-01-15140CALL0 096.15TRUE00
2027-01-15150CALL0 16996.21TRUE00
2027-01-15160CALL0 097.62TRUE00
2027-01-15175.85CALL0 788.18TRUE00
2027-01-15180CALL0 094.34TRUE00
2027-01-15190CALL0 394.85TRUE00
2027-01-15200CALL0 14193.92FALSE00
2027-01-15210CALL0 475.78FALSE00
2027-01-15220CALL0 712681.25FALSE00
2027-01-15230CALL0 389.27FALSE00
2027-01-15240CALL0 190.77FALSE00
2027-01-15250CALL0 3890.64FALSE00
2027-01-15260CALL0 289.77FALSE00
2027-01-15270CALL0 7190.35FALSE00
2027-01-15280CALL0 090.68FALSE00
2027-01-15290CALL0 093.87FALSE00
2027-01-15302.55CALL40 4591.97FALSE2.550
2027-01-15310CALL0 593FALSE00
2027-01-15320CALL0 793.4FALSE00
2027-01-15330CALL0 1094.09FALSE00
2027-01-15340CALL0 097.46FALSE00
2027-01-15350CALL0 2499.78FALSE00
2027-01-15360CALL0 196.27FALSE00
2027-01-15370CALL0 497.4FALSE00
2027-01-15381.7CALL0 296.93FALSE00
2027-01-15391.7CALL5 2109.13FALSE1.70
2027-01-15401.6CALL0 257107.68FALSE00
2027-01-1511050CALL0 00FALSE00
2027-01-1511100CALL0 00FALSE00
2027-01-1511150CALL0 00FALSE00
2027-01-1511200CALL0 00FALSE00
2027-01-1511250CALL0 00FALSE00
2027-01-1511300CALL0 00FALSE00
2027-01-1511350CALL0 00FALSE00
2027-01-1511400CALL0 00FALSE00
2027-01-1511450CALL0 00FALSE00
2027-01-1511500CALL0 00FALSE00
2027-01-1511550CALL0 00FALSE00
2027-01-1511600CALL0 00FALSE00
2027-01-1511650CALL0 00FALSE00
2027-01-1511700CALL0 00FALSE00
2027-01-1511750CALL0 00FALSE00
2027-01-1511800CALL0 00FALSE00
2027-01-1511850CALL0 00FALSE00
2027-01-1511900CALL0 00FALSE00
2027-01-1511950CALL0 00FALSE00
2027-01-1516600CALL0 00FALSE00
2027-01-1516700CALL0 00FALSE00
2027-01-1516800CALL0 00FALSE00
2027-01-1516900CALL0 00FALSE00
2027-01-1517000CALL0 00FALSE00
2027-01-1517100CALL0 00FALSE00
2027-01-1517200CALL0 00FALSE00
2027-01-1530PUT0 0244.08FALSE00
2027-01-1550PUT0 2195.95FALSE00
2027-01-1580PUT0 4139.58FALSE00
2027-01-1590PUT0 2127.25FALSE00
2027-01-15100PUT0 3116.23FALSE00
2027-01-15110PUT0 0108.59FALSE00
2027-01-15120PUT0 0101.28FALSE00
2027-01-15130PUT0 597.5FALSE00
2027-01-15140PUT0 292.19FALSE00
2027-01-15150PUT0 1690.68FALSE00
2027-01-15160PUT0 588.57FALSE00
2027-01-15170PUT0 486.96FALSE00
2027-01-15180PUT0 287.21FALSE00
2027-01-15190PUT0 086.37TRUE00
2027-01-15200PUT0 187.29TRUE00
2027-01-15210PUT0 284.57TRUE00
2027-01-15220PUT0 1084.08TRUE00
2027-01-15230PUT0 084.04TRUE00
2027-01-15240PUT0 084.46TRUE00
2027-01-15250PUT0 10784.51TRUE00
2027-01-15260PUT0 084.22TRUE00
2027-01-15270PUT0 084.5TRUE00
2027-01-15280PUT0 087.2TRUE00
2027-01-15290PUT0 083.24TRUE00
2027-01-15300PUT0 8982.61TRUE00
2027-01-15310PUT0 082.69TRUE00
2027-01-15320PUT0 085.52TRUE00
2027-01-15330PUT0 087.24TRUE00
2027-01-15340PUT0 091.83TRUE00
2027-01-15350PUT0 092.33TRUE00
2027-01-15360PUT0 090.57TRUE00
2027-01-15370PUT0 190.65TRUE00
2027-01-15380PUT0 083.45TRUE00
2027-01-15390PUT0 085.51TRUE00
2027-01-15400PUT0 783.51TRUE00
2027-01-1511050PUT0 00TRUE00
2027-01-1511100PUT0 00TRUE00
2027-01-1511150PUT0 00TRUE00
2027-01-1511200PUT0 00TRUE00
2027-01-1511250PUT0 00TRUE00
2027-01-1511300PUT0 00TRUE00
2027-01-1511350PUT0 00TRUE00
2027-01-1511400PUT0 00TRUE00
2027-01-1511450PUT0 00TRUE00
2027-01-1511500PUT0 00TRUE00
2027-01-1511550PUT0 00TRUE00
2027-01-1511600PUT0 00TRUE00
2027-01-1511650PUT0 00TRUE00
2027-01-1511700PUT0 00TRUE00
2027-01-1511750PUT0 00TRUE00
2027-01-1511800PUT0 00TRUE00
2027-01-1511850PUT0 00TRUE00
2027-01-1511900PUT0 00TRUE00
2027-01-1511950PUT0 00TRUE00
2027-01-1516600PUT0 00TRUE00
2027-01-1516700PUT0 00TRUE00
2027-01-1516800PUT0 00TRUE00
2027-01-1516900PUT0 00TRUE00
2027-01-1517000PUT0 00TRUE00
2027-01-1517100PUT0 00TRUE00
2027-01-1517200PUT0 00TRUE00
2028-01-2130CALL0 1108.81TRUE00
2028-01-2150CALL0 099.56TRUE00
2028-01-2180CALL0 085.24TRUE00
2028-01-21100CALL0 3982.05TRUE00
2028-01-21130CALL0 381.12TRUE00
2028-01-21150CALL0 182.22TRUE00
2028-01-21170CALL0 681.86TRUE00
2028-01-21200CALL0 11481.16FALSE00
2028-01-21220CALL0 381.71FALSE00
2028-01-21250CALL0 11578.62FALSE00
2028-01-21270CALL0 8477.83FALSE00
2028-01-21300CALL0 10278.52FALSE00
2028-01-21320CALL0 076.77FALSE00
2028-01-21350CALL0 676.18FALSE00
2028-01-21370CALL0 8078.95FALSE00
2028-01-21400CALL0 1677.41FALSE00
2028-01-2116600CALL0 00FALSE00
2028-01-2116800CALL0 00FALSE00
2028-01-2117000CALL0 00FALSE00
2028-01-2117200CALL0 00FALSE00
2028-01-2130PUT0 0303.89FALSE00
2028-01-2150PUT0 0176.99FALSE00
2028-01-2180PUT0 0117.03FALSE00
2028-01-21100PUT0 393.82FALSE00
2028-01-21130PUT0 6991.02FALSE00
2028-01-21150PUT0 275.9FALSE00
2028-01-21170PUT0 974.03FALSE00
2028-01-21200PUT0 075.48TRUE00
2028-01-21220PUT0 277.1TRUE00
2028-01-21250PUT0 11575.35TRUE00
2028-01-21270PUT0 075.28TRUE00
2028-01-21300PUT0 074.25TRUE00
2028-01-21320PUT0 175.63TRUE00
2028-01-21350PUT0 175.69TRUE00
2028-01-21370PUT0 073.46TRUE00
2028-01-21400PUT0 2975.09TRUE00
2028-01-2116600PUT0 00TRUE00
2028-01-2116800PUT0 00TRUE00
2028-01-2117000PUT0 00TRUE00
2028-01-2117200PUT0 00TRUE00

Latest SNDX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST3$15.6
Jun 13, 2022 7:59 PM EST4$15.6
Jun 13, 2022 7:59 PM EST1$15.6
Jun 13, 2022 7:59 PM EST100$15.61
Jun 13, 2022 7:59 PM EST45$15.61

Syndax Pharmaceuticals, Inc (SNDX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020028764/0001564590-20-028764-index.htm
2019-09-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1395937/000000000019013216/0000000000-19-013216-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000021545719006549/0000215457-19-006549-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000083423720006818/0000834237-20-006818-index.htm
2020-09-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000083423720010194/0000834237-20-010194-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090221919000254/0000902219-19-000254-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090221920000308/0000902219-20-000308-index.htm
2019-04-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090266419001816/0000902664-19-001816-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090266420000971/0000902664-20-000971-index.htm
2020-11-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000091957420006675/0000919574-20-006675-index.htm
2018-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000092189518001976/0000921895-18-001976-index.htm
2018-11-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189518003173/0000921895-18-003173-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189519000467/0000921895-19-000467-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189520000574/0000921895-20-000574-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000101359419000160/0001013594-19-000160-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000101359420000127/0001013594-20-000127-index.htm
2018-04-10DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000114036118018005/0001140361-18-018005-index.htm
2018-04-10DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1395937/000114036118018007/0001140361-18-018007-index.htm
2018-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312518197997/0001193125-18-197997-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312519034379/0001193125-19-034379-index.htm
2019-03-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519088951/0001193125-19-088951-index.htm
2019-03-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312519092679/0001193125-19-092679-index.htm
2019-03-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519092701/0001193125-19-092701-index.htm
2019-08-30S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1395937/000119312519235283/0001193125-19-235283-index.htm
2019-09-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1395937/000119312519239953/0001193125-19-239953-index.htm
2019-09-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519242045/0001193125-19-242045-index.htm
2019-10-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312519265254/0001193125-19-265254-index.htm
2020-02-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312520022917/0001193125-20-022917-index.htm
2020-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312520023646/0001193125-20-023646-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312520037637/0001193125-20-037637-index.htm
2020-05-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312520139263/0001193125-20-139263-index.htm
2018-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002680/0001562180-18-002680-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002681/0001562180-18-002681-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002682/0001562180-18-002682-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002683/0001562180-18-002683-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002684/0001562180-18-002684-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002685/0001562180-18-002685-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004047/0001562180-18-004047-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004048/0001562180-18-004048-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004049/0001562180-18-004049-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004050/0001562180-18-004050-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004443/0001562180-18-004443-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000852/0001562180-19-000852-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000853/0001562180-19-000853-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000854/0001562180-19-000854-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000855/0001562180-19-000855-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000856/0001562180-19-000856-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2019-03-254/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002023/0001562180-19-002023-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003487/0001562180-19-003487-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003488/0001562180-19-003488-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003489/0001562180-19-003489-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003490/0001562180-19-003490-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003491/0001562180-19-003491-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003492/0001562180-19-003492-index.htm
2019-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003880/0001562180-19-003880-index.htm
2019-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019005140/0001562180-19-005140-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020000891/0001562180-20-000891-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001228/0001562180-20-001228-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001229/0001562180-20-001229-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001230/0001562180-20-001230-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001231/0001562180-20-001231-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001232/0001562180-20-001232-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001233/0001562180-20-001233-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001234/0001562180-20-001234-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001235/0001562180-20-001235-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001236/0001562180-20-001236-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001237/0001562180-20-001237-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001238/0001562180-20-001238-index.htm
2020-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020005074/0001562180-20-005074-index.htm
2020-07-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020005102/0001562180-20-005102-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2018-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018004520/0001564590-18-004520-index.htm
2018-03-0810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459018004911/0001564590-18-004911-index.htm
2018-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018011784/0001564590-18-011784-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018012378/0001564590-18-012378-index.htm
2018-05-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018014349/0001564590-18-014349-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018019907/0001564590-18-019907-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018020483/0001564590-18-020483-index.htm
2018-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459018020504/0001564590-18-020504-index.htm
2018-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018023593/0001564590-18-023593-index.htm
2018-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018026817/0001564590-18-026817-index.htm
2018-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018026892/0001564590-18-026892-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019002676/0001564590-19-002676-index.htm
2019-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459019006772/0001564590-19-006772-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019006777/0001564590-19-006777-index.htm
2019-03-1810-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459019008313/0001564590-19-008313-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000156459019014263/0001564590-19-014263-index.htm
2019-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019015972/0001564590-19-015972-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019017318/0001564590-19-017318-index.htm
2019-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019022241/0001564590-19-022241-index.htm
2019-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019024625/0001564590-19-024625-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019030050/0001564590-19-030050-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019030067/0001564590-19-030067-index.htm
2019-08-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459019030084/0001564590-19-030084-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019036518/0001564590-19-036518-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019041712/0001564590-19-041712-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019041719/0001564590-19-041719-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019045581/0001564590-19-045581-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020004037/0001564590-20-004037-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020005551/0001564590-20-005551-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020008426/0001564590-20-008426-index.htm
2020-03-0510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459020009016/0001564590-20-009016-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000156459020019694/0001564590-20-019694-index.htm
2020-04-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020019928/0001564590-20-019928-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020019941/0001564590-20-019941-index.htm
2020-05-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020020574/0001564590-20-020574-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020020633/0001564590-20-020633-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020022849/0001564590-20-022849-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020022971/0001564590-20-022971-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020028764/0001564590-20-028764-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020031882/0001564590-20-031882-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020037719/0001564590-20-037719-index.htm
2020-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459020037767/0001564590-20-037767-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020037777/0001564590-20-037777-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020049638/0001564590-20-049638-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020051287/0001564590-20-051287-index.htm
2019-09-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1395937/999999999519002056/9999999995-19-002056-index.htm
2018-11-27CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999716026189/9999999997-16-026189-index.htm
2018-04-03CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718004150/9999999997-18-004150-index.htm
2018-06-13CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718006372/9999999997-18-006372-index.htm
2018-08-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718007508/9999999997-18-007508-index.htm
2018-12-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718009113/9999999997-18-009113-index.htm
2019-03-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999719002097/9999999997-19-002097-index.htm

Syndax Pharmaceuticals, Inc (SNDX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Syndax Pharmaceuticals, Inc (SNDX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 645%
Institutional Ownership: 7888%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-04-03Peter OrdentlichChief Scientific OfficerSell7,500.0015.00112,500.000.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm
2020-07-06Michael L. MeyersSVP, Chief Medical OfficerBuy3,500.0010,730.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020005074/0001562180-20-005074-index.htm
2020-11-04Michael A MetzgerPresident and COOBuy100,000.007.20720,000.00117,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2019-05-09Briggs MorrisonChief Executive OfficerBuy13,200.007.5699,726.0013,200.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2020-02-12Michael A MetzgerPresident and COOBuy15,000.0017,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020001238/0001562180-20-001238-index.htm
2020-11-04Michael A MetzgerPresident and COOSell100,000.0020.312,031,410.0017,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2019-05-13Briggs MorrisonChief Executive OfficerBuy7,200.007.2952,516.8020,400.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2018-10-30Michael L. MeyersSVP, Chief Medical OfficerBuy200.004.79958.002,398.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018004443/0001562180-18-004443-index.htm
2019-10-10Briggs MorrisonChief Executive OfficerBuy11,000.005.4059,400.0031,400.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019005140/0001562180-19-005140-index.htm
2020-02-04Briggs MorrisonChief Executive OfficerBuy12,500.008.00100,000.0043,900.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020000891/0001562180-20-000891-index.htm
2019-03-21Michael L. MeyersSVP, Chief Medical OfficerBuy1,000.004.934,930.007,118.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2019-03-21Michael L. MeyersSVP, Chief Medical OfficerBuy104.004.87506.487,222.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2018-04-03Peter OrdentlichChief Scientific OfficerBuy7,500.003.0823,100.007,500.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm